However, it does not appear to be the case that PRMT1 mutations are generally rare in cancers, with 9.0% (1024/11,315) of samples in The Cancer Genome Atlas (TCGA) harboring PRMT1 mutations. This evidence concerns the gene PRMT1 and cancer.